SCHEMBL23735925

SCHEMBL23735925

CCc1cc(O)cc2cc(F)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.51
ESR2 Q92731 6/20 0.51
HSD17B3 P37058 1/20 0.39
FLT3 P36888 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA9 Q16790 1/20 0.37
MAPT P10636 3/20 0.36
HTT P42858 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ESRRB O95718 1/20 0.36
ESRRA P11474 1/20 0.36
PKM P14618 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
DAO P14920 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26884639 0.86 ESR1 (0.63) ESR1ESR2HSD17B3FLT3MAPT
SCHEMBL3959232 0.76 NQO2 (0.55) ESR1ESR2MAPTKDM4EHSD17B10
SCHEMBL30080007 0.75 NQO2 (0.54) ESR1ESR2FLT3CA12CA1
SCHEMBL22275563 0.75 NQO2 (0.54) ESR1ESR2FLT3CA12CA1
SCHEMBL3849718 0.74 CA3 (0.52) ESR1ESR2CA9MAPTHTT
SCHEMBL26886566 0.74 CYP1A2 (0.43) MAPTPKMSMN1; SMN2DAOMEN1
SCHEMBL20314903 0.71 CA1 (0.37) ESR1ESR2FLT3CA12CA1
SCHEMBL21610039 0.70 ESR1 (0.43) ESR1ESR2HSD17B3KDM4EESRRB
SCHEMBL26736318 0.69 CYP1A2 (0.41) ESR1ESR2MAPTKDM4EHSD17B10
SCHEMBL13960115 0.69 ESR1 (0.80) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558955-B1 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER AMGEN INC (US) 2021-08-11 EP disclosed